Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Edgerton

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Molecular Cancer|December 22, 2010
Downregulation of miR-342 is associated with tamoxifen resistant breast tumorsDiana M Cittelly, Partha M Das, Nicole S Spoelstra, et al.
Cell Cycle (Georgetown, Tex.)|December 23, 2011
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancersXin-Sheng Deng, Shuiliang Wang, Anlong Deng, et al.
Mucosal Immunology|February 25, 2011
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndromeH R Conti, O Baker, A F Freeman, et al.
Breast Cancer Research : BCR|April 1, 2014
Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodelingSonali Jindal, Dexiang Gao, Pat Bell, et al.
Cancer Research|January 15, 1991
pS2 expression and response to hormonal therapy in patients with advanced breast cancerL H Schwartz, F C Koerner, S M Edgerton, et al.
Journal of Leukocyte Biology|June 19, 2001
A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptorsC Blanpain, R Buser, C A Power, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patientsClaire L Ihle, Meredith D Provera, Desiree M Straign, et al.
Journal of the National Cancer Institute|July 5, 1995
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinomaK Axelsson, B M Ljung, D H Moore, et al.
Breast Cancer Research : BCR|September 20, 2005
Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cellsAeree Kim, Bolin Liu, Dalia Ordonez-Ercan, et al.
Hormones & Cancer|September 13, 2014
Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bReema S Wahdan-Alaswad, Dawn R Cochrane, Nicole S Spoelstra, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Molecular Cancer|December 22, 2010
Downregulation of miR-342 is associated with tamoxifen resistant breast tumorsDiana M Cittelly, Partha M Das, Nicole S Spoelstra, et al.
Cell Cycle (Georgetown, Tex.)|December 23, 2011
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancersXin-Sheng Deng, Shuiliang Wang, Anlong Deng, et al.
Mucosal Immunology|February 25, 2011
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndromeH R Conti, O Baker, A F Freeman, et al.
Breast Cancer Research : BCR|April 1, 2014
Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodelingSonali Jindal, Dexiang Gao, Pat Bell, et al.
Cancer Research|January 15, 1991
pS2 expression and response to hormonal therapy in patients with advanced breast cancerL H Schwartz, F C Koerner, S M Edgerton, et al.
Journal of Leukocyte Biology|June 19, 2001
A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptorsC Blanpain, R Buser, C A Power, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patientsClaire L Ihle, Meredith D Provera, Desiree M Straign, et al.
Journal of the National Cancer Institute|July 5, 1995
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinomaK Axelsson, B M Ljung, D H Moore, et al.
Breast Cancer Research : BCR|September 20, 2005
Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cellsAeree Kim, Bolin Liu, Dalia Ordonez-Ercan, et al.
Hormones & Cancer|September 13, 2014
Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bReema S Wahdan-Alaswad, Dawn R Cochrane, Nicole S Spoelstra, et al.
Pageof 9